Biosafety and Health

Title Publication Date Language Citations
Use of antimicrobials in food animals and impact of transmission of antimicrobial resistance on humans2021/02/01English171
Cold-chain transportation in the frozen food industry may have caused a recurrence of COVID-19 cases in destination: Successful isolation of SARS-CoV-2 virus from the imported frozen cod package surface2020/12/01English144
Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy2020/06/01English127
An update to monoclonal antibody as therapeutic option against COVID-192021/04/01English86
A strategy to prevent future epidemics similar to the 2019-nCoV outbreak2020/03/01English81
Charting the challenges behind the testing of COVID-19 in developing countries: Nepal as a case study2020/06/01English79
Human-animal interactions and bat coronavirus spillover potential among rural residents in Southern China2019/09/01English77
Prevalence and transmission of mobilized colistin resistance (mcr) gene in bacteria common to animals and humans2020/06/01English61
A review of artificial intelligence applications for antimicrobial resistance2021/02/01English60
Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 20172019/06/01English51
Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro2020/12/01English50
Biosynthesis, bioactivity, biotoxicity and applications of antimicrobial peptides for human health2022/04/01English39
SARS-CoV-2: A critical review of its history, pathogenesis, transmission, diagnosis and treatment2020/12/01English34
Advanced biosafety materials for prevention and theranostics of biosafety issues2022/04/01English31
Omicron variant of SARS-CoV-2 imposes a new challenge for the global public health2022/06/01English26
Spatiotemporal patterns and trends of community transmission of the pandemic COVID-19 in South Asia: Bangladesh as a case study2021/02/01English22
Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 20202020/12/01English21
Biosafety chemistry and biosafety materials: A new perspective to solve biosafety problems2022/02/01English20
Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment2020/12/01English20
Yersinia pestis, a problem of the past and a re-emerging threat2019/09/01English19
Clinical characteristics of patients diagnosed with COVID-19 in Beijing2020/06/01English19
Development of two multiplex real-time PCR assays for simultaneous detection and differentiation of monkeypox virus IIa, IIb, and I clades and the B.1 lineage2022/12/01English17
SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: A review2021/10/01English16
Convincing the confidence to conquer COVID-19: From epidemiological intervention to laboratory investigation2020/12/01English16
Facing the 2020 pandemic: What does cyberbiosecurity want us to know to safeguard the future?2021/02/01English15
The impact of sample processing on the rapid antigen detection test for SARS-CoV-2: Virus inactivation, VTM selection, and sample preservation2021/10/01English15
Biosafety assessment of delivery systems for clinical nucleic acid therapeutics2022/04/01English15
Expression pattern and function of SARS-CoV-2 receptor ACE22021/12/01English14
Combination of chemistry and material science to overcome health problems2022/04/01English14
Laboratory biosafety in China: past, present, and future2019/09/01English13